课题基金 / 基金详情

Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission

Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission
生物医学卓越研究中心 (COBRE) 更新(第 2 阶段)CNTN - 重新提交
批准号:
10688038
负责人:
JESSICA KIRKLAND CALDWELL
金额:
$223.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-09-01 至 2026-06-30

项目摘要

项目成果

JESSICA KIRKLAND CALDWELL的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY/ABSTRACT Overall Nevada (NV) is one of the 24 Institutional Development Award (IDeA) states affected by restricted research capacity. The overarching goal of our Center of Biomedical Research Excellence (COBRE) Center for Neurodegeneration and Translational Neuroscience (CNTN) is to establish translational neuroscience research infrastructure in Southern NV to develop innovative diagnostic methods and therapeutic interventions that can be applied across neurodegenerative disorders (NDD) and in diverse populations. The CNTN is highly significant for State representatives given the upcoming needs of age-related NDD healthcare due to the sustained increase in the population of NV, including retirees. Our thematically cohesive, multidisciplinary team comprises investigators from both the Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas (LRCBH), and the University of Nevada Las Vegas (UNLV). During the first five years of COBRE support, the CNTN has transformed the environment for translational neuroscience research in Southern NV. The main accomplishments of CNTN Phase 1 are: 1- the creation of a Brain Imaging Department at LRCBH dedicated to research endeavors; 2- the building of a research cohort comprising NDD subjects who are deeply phenotyped; 3- the establishment of a Data Management and Statistics Core; 4- the inauguration of a Department of Brain Health, whose Founding Chair was a CNTN Junior Investigator (JI); 5- the forming of a Community Advisory Board to assist with community outreach activities aimed at inviting diverse individuals to volunteer in clinical research projects; and 6- the increase in the critical mass of investigators. A promising group of JIs have leveraged the resources compiled by the CNTN to carry out highly innovative research projects. All the JIs have graduated from the CNTN program with independent funding and promotion within local or external high caliber institutions. Our Assessment Unit has created new assessment methods based on a Science of Team Science approach to assess the performance of each individual CNTN Core and JI. They demonstrated that increasing the size of a scientific networking results in the inflation of scientific products. In Phase 2, the CNTN intends to develop the resources and processes necessary to reach sustainability. For this, we are revising the CNTN leadership to tackle growing responsibilities. The evaluation reports produced by our Assessment Unit will be utilized to elaborate our strategy, monitor progress, and make eventual adjustments. Specifically, we plan to foster infrastructure development, strengthen the career development of CNTN investigators, launch a pilot project program, and stimulate research productivity. We anticipate that our efforts will result in new collaborations with academic and industry partners, which will put the CNTN on the path for sustainability.
期刊论文(113)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/cts.12491
发表时间: 2018-03
期刊: Clinical and translational science
影响因子: --
作者: [Cummings J]
通讯作者: Cummings J
DOI: 10.1186/s13195-017-0300-8
发表时间: 2017-09-12
期刊: Alzheimer's research & therapy
影响因子: --
作者: [Caldwell JZK, Berg JL, Cummings JL, Banks SJ, Alzheimer’s Disease Neuroimaging Initiative]
通讯作者: Alzheimer’s Disease Neuroimaging Initiative
DOI: 10.1016/j.phrs.2018.02.014
发表时间: 2018-04
期刊: Pharmacological research
影响因子: 9.3
作者: [Hampel H, Vergallo A, Aguilar LF, Benda N, Broich K, Cuello AC, Cummings J, Dubois B, Federoff HJ, Fiandaca M, Genthon R, Haberkamp M, Karran E, Mapstone M, Perry G, Schneider LS, Welikovitch LA, Woodcock J, Baldacci F, Lista S, Alzheimer Precision Medicine Initiative (APMI)]
通讯作者: Alzheimer Precision Medicine Initiative (APMI)
Peripheral Biomarkers for Alzheimer's Disease: Update and Progress.
阿尔茨海默病的外周生物标志物:更新和进展。
DOI: 10.1007/s40120-019-00171-6
发表时间: 2019
期刊: Neurology and therapy
影响因子: 3.7
作者: [Sabbagh,MarwanN, Blennow,Kaj]
通讯作者: Blennow,Kaj
54
    Interactions of Sex and Gender Factors in Risk for Alzheimers Disease: Links Between Stress, Neural Activity, Inflammation, and Memory
    • 批准号:
      10631992
    • 项目类别:
    • 资助金额:
      $45.74万
    • 财政年份:
      2021
    • 负责人:
      JESSICA KIRKLAND CALDWELL
    • 依托单位:
    Interactions of Sex and Gender Factors in Risk for Alzheimers Disease: Links Between Stress, Neural Activity, Inflammation, and Memory
    • 批准号:
      10456936
    • 项目类别:
    • 资助金额:
      $45.07万
    • 财政年份:
      2021
    • 负责人:
      JESSICA KIRKLAND CALDWELL
    • 依托单位:
    Interactions of Sex and Gender Factors in Risk for Alzheimers Disease: Links Between Stress, Neural Activity, Inflammation, and Memory
    • 批准号:
      10307848
    • 项目类别:
    • 资助金额:
      $48.38万
    • 财政年份:
      2021
    • 负责人:
      JESSICA KIRKLAND CALDWELL
    • 依托单位:
    CORE A: Administrative Core
    • 批准号:
      10688040
    • 项目类别:
    • 资助金额:
      $53.92万
    • 财政年份:
      2015
    • 负责人:
      JESSICA KIRKLAND CALDWELL
    • 依托单位: